Intelligent Bio Solutions Announces Adoption Of Its Non-Invasive Drug Screening Solution By Pyrotek, Helping Enhance Its Workplace Safety Protocols, Shifting From Traditional Saliva Testing To INBS' Faster, More Efficient Fingerprint Sweat-Based Drug Screening Method
Portfolio Pulse from Benzinga Newsdesk
Intelligent Bio Solutions Inc. (NASDAQ:INBS) has announced that Pyrotek Pty Ltd, a global engineering solutions leader, has adopted its non-invasive fingerprint sweat-based drug screening solution. This transition from traditional saliva testing will enhance Pyrotek's workplace safety protocols, allowing for in-house, efficient, and cost-effective drug testing.
October 14, 2024 | 12:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Intelligent Bio Solutions Inc. has secured a new client, Pyrotek Pty Ltd, for its fingerprint sweat-based drug screening solution. This partnership enhances Pyrotek's safety protocols and could boost INBS's market presence.
The adoption of INBS's drug screening solution by a global leader like Pyrotek is a significant endorsement of its technology. This could lead to increased market adoption and revenue growth for INBS, positively impacting its stock price.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90